Jeetinder Singh Mahal - 06 Feb 2026 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
CEO and President, Director
Signature
/s/ Herb Cross, as Attorney-in-Fact
Issuer symbol
JSPR
Transactions as of
06 Feb 2026
Net transactions value
$0
Form type
4
Filing time
10 Feb 2026, 16:00:23 UTC
Previous filing
05 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mahal Jeetinder Singh CEO and President, Director C/O JASPER THERAPEUTICS, INC., 2200 BRIDGE PKWY, SUITE 102, REDWOOD CITY /s/ Herb Cross, as Attorney-in-Fact 10 Feb 2026 0001882877

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +500,000 $0.000000 500,000 06 Feb 2026 Voting Common Stock 500,000 $1.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on February 6, 2027, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.